OFFICE OF FISCAL ANALYSIS

Legislative Office Building, Room 5200

Hartford, CT 06106 (860) 240-0200

http://www.cga.ct.gov/ofa

sHB-5537

AN ACT CONCERNING VARIOUS REVISIONS TO THE PUBLIC HEALTH STATUTES.

As Amended by House "A" (LCO 5611)

House Calendar No.: 337

Senate Calendar No.: 567

OFA Fiscal Note

State Impact: See Below

Municipal Impact: None

Explanation

The sections that result in a fiscal impact are detailed below. The remaining sections make technical changes to existing public health statutes, codify current practice,1 or create new statutory provisions that do not result in fiscal impact.

Section 2, which makes engaging in tattooing without a license or temporary permit a class D misdemeanor, results in a potential minimal General Fund revenue gain to the extent that individuals are found guilty and fined up to $250.

Sections 503 and 504 result in a potential cost to the Department of Correction and the Judicial Department associated with making violators of music therapist (Section 503) and art therapist (Section 504) statutes guilty of a class D felony. To the extent that offenders are prosecuted for new or expanded offenses under this bill, potential costs for incarceration or probation supervision in the community, or judicial revenue would result. On average, it costs the state $7,260 (including benefits) to supervise an inmate in the community as opposed to $61,320 (including benefits) to incarcerate an offender.

Section 512 may result in a cost of less than $1,000 in FY 17 to those agencies participating in a working group to reimburse legislators and agency staff for mileage expenses.

Section 513 may result in a revenue loss to the Department of Social Services (DSS) if DSS elects to waive the recoupment of overpayments to certain hospitals. 

Section 514 may result in a cost of less than $1,000 in FY 17 to those agencies participating in a task force to reimburse legislators and agency staff for mileage expenses.

Section 516 requires the Office of Policy and Management (OPM), not later than 10/1/16, to issue a request for information from nonprofits regarding their ability to serve as Connecticut's protection and advocacy (P&A) system. It is anticipated that, pursuant to the Governor's designation of the P&A nonprofit, OPM will contract with this entity beginning 7/1/17. This will result in a contract cost to OPM in FY 18, the amount of which is unknown at this time. Nevertheless, it is anticipated that the privatization of these services will yield significant General Fund savings associated with Personal Services, fringe benefits, and the leasing of office space. Currently, there are 12 positions in the Office of Protection and Advocacy (OPA) associated with P&A services.

Section 517 abolishes OPA in FY 18. Pursuant to Section 516, P&A functions will be provided by a nonprofit. Pursuant to Section 518 investigations of allegations of abuse or neglect will be performed by Department of Rehabilitative Services (DORS). It is anticipated that approximately $1.2 million and 11 positions will be transferred to DORS in FY 18.

Section 519 establishes a Diabetes Advisory Council within the Department of Public Health within available appropriations, resulting in a potential cost of less than $1,000 in FY 17 and FY 18 for members incurring necessary expenses in the performance of their duties, such as mileage reimbursement.

House “A” added additional provisions to the underlying bill. Those that result in a fiscal impact are identified above.

The Out Years

The fiscal impact identified above will continue into the future to the extent that: (1) individuals are found guilty of new offenses, (2) DSS elects to waive the recoupment of overpayments to certain hospitals, and (3) savings resulting from the privatization of P&A and the transfer of OPA investigations to DORS.

1 This includes the fee increase, from $50 to $100, for a hairdresser's license without examination, due to licensure in another jurisdiction. The Department of Public Health currently charges $100, not $50, for this license. It also includes newborn screening for adrenoleukodystrophy, for which is currently underway.